Home

Paul Rutherford Carter

CIK 1600041 · EVP Commercial Ops · last filed 2026-06-18

Paul Rutherford Carter is an EVP Commercial Ops who has filed 55 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for IMTX, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$27.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.68M

Companies

4

Total Filings

55

Lifetime Open-Market Net

-$27.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMTX Director — $9.87 — $0 1 2026-06-18
Keenova Therapeutics plc (MNK) Delisted Director 0 $0.34 $0 $0 4 2022-06-21
ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted Director — — — $0 5 2019-05-28
GILD EVP Commercial Ops 64,305 $135.00 $8.68M -$27.47M 44 2016-08-03

Recent Filings

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 IMTX Grant (A) — $0 EDGAR
2022-06-21 Keenova Therapeutics plc (MNK) Delisted Disp (D) −20,320 $0 EDGAR
2020-05-15 Keenova Therapeutics plc (MNK) Delisted Tax (F) −9,117 -$27.0K EDGAR
2019-10-24 — Disp (D) — $0
2019-05-28 ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted Grant (A) — $0 EDGAR
2019-05-17 Keenova Therapeutics plc (MNK) Delisted Mixed +10,490 -$135.5K EDGAR
2018-05-25 ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted Grant (A) — $0 EDGAR
2018-05-18 Keenova Therapeutics plc (MNK) Delisted Grant (A) +18,947 $0 EDGAR
2017-05-26 ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted Grant (A) — $0 EDGAR
2016-08-03 GILD Mixed — -$81.4K EDGAR
Showing 1–10 of 55
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.